Publication | Open Access
Targeting Inhibitors of the Tumor Suppressor PP2A for the Treatment of Pancreatic Cancer
110
Citations
49
References
2014
Year
The PP2A inhibitors SET and CIP2A are overexpressed in human pancreatic cancer and are important for pancreatic cancer cell growth and transformation; thus, antagonizing SET and/or CIP2A may be an innovative approach for the treatment of human pancreatic cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1